Author:
Steybe David,Poxleitner Philipp,Voss Pit Jacob,Metzger Marc Christian,Schmelzeisen Rainer,Bamberg Fabian,Kim Suam,Russe Maximilian Frederik
Abstract
Abstract
Background
Intraoperative incorporation of radiopaque fiducial markers at the tumor resection surface can provide useful assistance in identifying the tumor bed in postoperative imaging for RT planning and radiological follow-up. Besides titanium clips, iodine containing injectable liquid fiducial markers represent an option that has emerged more recently for this purpose. In this study, marking oral soft tissue resection surfaces, applying low dose injections of a novel Conformité Européenne (CE)-marked liquid fiducial marker based on sucrose acetoisobutyrate (SAIB) and iodinated SAIB (x-SAIB) was investigated.
Methods
Visibility and discriminability of low dose injections of SAIB/x-SAIB (10 µl, 20 µl, 30 µl) were systematically studied at different kV settings used in clinical routine in an ex-vivo porcine mandible model. Transferability of the preclinical results into the clinical setting and applicability of DE-CT were investigated in initial patients.
Results
Markers created by injection volumes as low as 10 µl were visible in CT imaging at all kV settings applied in clinical routine (70–120 kV). An injection volume of 30 µl allowed differentiation from an injection volume of 10 µl. In a total of 118 injections performed in two head and neck cancer patients, markers were clearly visible in 83% and 86% of injections. DE-CT allowed for differentiation between SAIB/x-SAIB markers and other hyperdense structures.
Conclusions
Injection of low doses of SAIB/x-SAIB was found to be a feasible approach to mark oral soft tissue resection surfaces, with injection volumes as low as 10 µl found to be visible at all kV settings applied in clinical routine. With the application of SAIB/x-SAIB reported for tumors of different organs already, mostly applying relatively large volumes for IGRT, this study adds information on the applicability of low dose injections to facilitate identification of the tumor bed in postoperative CT and on performance of the marker at different kV settings used in clinical routine.
Funder
Universitätsklinikum Freiburg
Publisher
Springer Science and Business Media LLC
Subject
Radiology Nuclear Medicine and imaging
Reference31 articles.
1. Kirova YM, Fournier-Bidoz N, Servois V, Laki F, Pollet GA, Salmon R, et al. How to boost the breast tumor bed? A multidisciplinary approach in eight steps. Int J Radiat Oncol Biol Phys. 2008;72:494–500.
2. Furet E, Peurien D, Fournier-Bidoz N, Servois V, Reyal F, Fourquet A, et al. Plastic surgery for breast conservation therapy: How to define the volume of the tumor bed for the boost? Eur J Surg Oncol EJSO. 2014;40:830–4.
3. Bedwinek J. Breast conserving surgery and irradiation: the importance of demarcating the excision cavity with surgical clips. Int J Radiat Oncol. 1993;26:675–9.
4. Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF): S3-Leitlinie Diagnostik und Therapie des Mundhöhlenkarzinoms, Langversion 3.0. 2021. https://www.leitlinienprogramm-onkologie.de/leitlinien/mundhoehlenkarzinom/. Accessed 4 May 2021.
5. Studer G, Furrer K, Davis BJ, Stoeckli SS, Zwahlen RA, Luetolf UM, et al. Postoperative IMRT in head and neck cancer. Radiat Oncol Lond Engl. 2006;1:40.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献